Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02409095Phase 4Terminated
A Phase 4 trial of diphtheria, tetanus, pertussis (whole cell), hepatitis B and haemophilus influenzae type b vaccine in diphtheria, Tetanus, pertussis, hepatitis B (HBV), Haemophilus influenzae type b infection (Hib), sponsored by Serum Institute of India. Started Jan 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02409095.